Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Lipkowitz Website

Stanley Lipkowitz, M.D., Ph.D.

Selected Publications

1)  Ryan PE, Kales SC, Yadavalli R, Nau MM, Zhang H, Lipkowitz S.
Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5.
PLoS ONE. 7: e49428, 2012.
[Journal]
2)  Guo H, Qiao G, Ying H, Li Z, Zhao Y, Liang Y, Yang L, Lipkowitz S, Penninger JM, Langdon WY, Zhang J.
E3 Ubiquitin Ligase Cbl-b Regulates Pten via Nedd4 in T Cells Independently of Its Ubiquitin Ligase Activity.
Cell Rep. 1: 472-482, 2012.
[Journal]
3)  Kales SC, Ryan PE, Lipkowitz S.
Cbl exposes its RING finger.
Nat. Struct. Mol. Biol. 19: 131-3, 2012.
[Journal]
4)  Garimella SV, Rocca A, Lipkowitz S.
WEE1 Inhibition Sensitizes Basal Breast Cancer Cells to TRAIL-Induced Apoptosis.
Mol. Cancer Res. 10: 75-85, 2012.
[Journal]
5)  Lipkowitz S, Weissman AM.
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis.
Nat. Rev. Cancer. 11: 629-43, 2011.
[Journal]
6)  Chavez KJ, Garimella SV, Lipkowitz S.
Triple Negative Breast Cancer Cell Lines: One Tool in the Search for Better Treatment of Triple Negative Breast Cancer.
Breast Dis. 32: 35-48, 2011.
[Journal]
7)  Yoon HY, Kales SC, Luo R, Lipkowitz S, Randazzo PA.
ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking.
Biol. Cell. 103: 171-84, 2011.
[Journal]
8)  Ryan PE, Sivadasan-Nair N, Nau MM, Nicholas S, Lipkowitz S.
The N-terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin conjugating enzyme.
J Biol Chem. 285: 23687-98, 2010.
[Journal]
9)  Kales SC, Ryan PE, Nau MM, Lipkowitz S.
Cbl and human myeloid neoplasms: the Cbl oncogene comes of age.
Cancer Res. 70: 4789-94, 2010.
[Journal]
10)  Tan YH, Krishnaswamy S, Nandi S, Kanteti R, Vora S, Onel K, Hasina R, Lo FY, El-Hashani E, Cervantes G, Robinson M, Kales SC, Lipkowitz S, Karrison T, Sattler M, Vokes EE, Wang YC, Salgia R.
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.
PLoS ONE. 5: e8972, 2010.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 4/18/2013.